The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.3. rezultāts no 80.
407. lappuse
... period for response to an office action allowed by statute is six months , but the Commissioner may set a shortened statutory period for response of not less than 30 days . ( Rule 136 ) . The applicant or his attorney will carefully ...
... period for response to an office action allowed by statute is six months , but the Commissioner may set a shortened statutory period for response of not less than 30 days . ( Rule 136 ) . The applicant or his attorney will carefully ...
456. lappuse
... period . " Just as soon as it is clear that there is any unexcused gap in diligence during the critical period , we revert to our basic rule that the first to re- duce to practice is the first inventor . It should be noted that ...
... period . " Just as soon as it is clear that there is any unexcused gap in diligence during the critical period , we revert to our basic rule that the first to re- duce to practice is the first inventor . It should be noted that ...
474. lappuse
... period . Va- cation periods of applicant and attorney and reasonable interruptions for other work may constitute such excuses where properly proved . We have noted that work in perfecting the invention or prepara- tion and filing of a ...
... period . Va- cation periods of applicant and attorney and reasonable interruptions for other work may constitute such excuses where properly proved . We have noted that work in perfecting the invention or prepara- tion and filing of a ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention